午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

6-amino-8-[4-(methylsulfanyl)phenyl]-2-propyl-2,3,8,8a-tetrahydro-5,7,7(1H)-isoquinolinetricarbonitrile

CAS No.
294878-05-0
Chemical Name:
6-amino-8-[4-(methylsulfanyl)phenyl]-2-propyl-2,3,8,8a-tetrahydro-5,7,7(1H)-isoquinolinetricarbonitrile
Synonyms
5,7,7(1H)-Isoquinolinetricarbonitrile, 6-amino-2,3,8,8a-tetrahydro-8-[4-(methylthio)phenyl]-2-propyl-;6-amino-8-[4-(methylsulfanyl)phenyl]-2-propyl-2,3,8,8a-tetrahydro-5,7,7(1H)-isoquinolinetricarbonitrile
CBNumber:
CB21942400
Molecular Formula:
C22H23N5S
Molecular Weight:
389.52
MDL Number:
MOL File:
294878-05-0.mol

6-amino-8-[4-(methylsulfanyl)phenyl]-2-propyl-2,3,8,8a-tetrahydro-5,7,7(1H)-isoquinolinetricarbonitrile Properties

Boiling point 694.0±55.0 °C(Predicted)
Density 1.27±0.1 g/cm3(Predicted)
pka 5.60±0.70(Predicted)

6-amino-8-[4-(methylsulfanyl)phenyl]-2-propyl-2,3,8,8a-tetrahydro-5,7,7(1H)-isoquinolinetricarbonitrile Preparation Products And Raw materials

Raw materials

Preparation Products

6-amino-8-[4-(methylsulfanyl)phenyl]-2-propyl-2,3,8,8a-tetrahydro-5,7,7(1H)-isoquinolinetricarbonitrile Suppliers

Global( 2)Suppliers
Supplier Tel Email Country ProdList Advantage
PHARMEKS Ltd. -- sales@pharmeks.com Finland 6349 50
Specs -- info@specs.net The Netherlands 6833 70
Supplier Advantage
PHARMEKS Ltd. 50
Specs 70
6-amino-8-[4-(methylsulfanyl)phenyl]-2-propyl-2,3,8,8a-tetrahydro-5,7,7(1H)-isoquinolinetricarbonitrile 5,7,7(1H)-Isoquinolinetricarbonitrile, 6-amino-2,3,8,8a-tetrahydro-8-[4-(methylthio)phenyl]-2-propyl- 294878-05-0
This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept